BioCentury | Apr 2, 2021
Management Tracks

O’Brien to head NPC; plus moves at Frontier, Araris, Montis and more

...cell and gene therapy business at Cytiva, formerly known as GE Healthcare Life Sciences.Extended release drug developers Lyndra Therapeutics Inc....
...is stepping down as general partner at Google Ventures to launch his own venture firm, Byers Capital. BC Staff Lyndra Therapeutics Inc. Janux...
BioCentury | Oct 20, 2020
Management Tracks

J&J promotes Kumar; plus moves at Krystal, Design, Centogene, Lyndra, Mereo and Neoleukin

...was associate general counsel at the non-profit.Could an IPO soon be in the works for Lyndra Therapeutics Inc....
...companies public. The addition of  Eldridge is the third senior management hire this year for Lyndra...
...to serve on Mereo’s board. Danielle Golovin Krystal Biotech Inc. Design Therapeutics Inc. Mereo BioPharma Group plc Neoleukin Therapeutics Inc. Centogene N.V. Lyndra Therapeutics Inc....
BioCentury | Dec 6, 2019
Preclinical News

Dec. 5 Preclinical Quick Takes: Simpler synthesis of Merck’s HIV therapy; plus MRSA antibiotic, once-monthly oral contraceptive

...infected moth larvae. MIT’s once-monthly oral contraceptive A Massachusetts Institute of Technology team led by Lyndra Therapeutics Inc....
...contraceptive was detected in serum up to 29 days after oral delivery of the capsule. Lyndra...
...infectious and neurological diseases, transplant rejection and contraception (see “Star Treatment” ). BioCentury Staff Massachusetts Institute of Technology Lyndra Therapeutics Inc. MRSA antibiotic antimicrobial...
BioCentury | Oct 4, 2019
Company News

Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more

...CSO. Bellinger is an attending cardiologist at Brigham and Women's Hospital and was CSO at Lyndra Therapeutics Inc....
BioCentury | Jul 9, 2019
Company News

July 9 Company Quick Takes: Celgene, Nimbus expand deal; plus Gilead-Lyndra, Darzalex and more

...Gilead, Lyndra to develop long-acting HIV therapies Gilead Sciences Inc. (NASDAQ:GILD) gained exclusive rights from Lyndra Therapeutics Inc....
...Financial terms are undisclosed. Gilead participated in Lyndra's $60.9 million series B in January (see "Lyndra...
...Writer Darzalex, daratumumab (JNJ-54767414, humax-cd38) SP-1373, VPD-107 tislelizumab (BGB-A317) Alector Inc. Altimmune Inc. BeiGene Ltd. Gilead Sciences Inc. Johnson & Johnson WinterLight Labs Inc. Celgene Corp. Lyndra Therapeutics Inc. Nimbus...
BioCentury | Jun 3, 2019
Company News

Management tracks: Zai, Jazz, PTC, BIO and more

...biopharma division of the GE Healthcare unit of General Electric Co. (NYSE:GE). Drug delivery company Lyndra Therapeutics Inc....
...at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). Mark Zipkin, Staff Writer Biotechnology Innovation Organization Leo Pharma A/S PTC Therapeutics Inc. Jazz Pharmaceuticals plc Lyndra Therapeutics Inc. Zai...
BioCentury | Mar 13, 2019
Preclinical News

Langer study describes once-monthly dosing system for tuberculosis

...The scientific team behind drug delivery company Lyndra Therapeutics described a delivery device capable of releasing...
...treatment regimens last 6-9 months, according to the CDC. Langer and Traverso are co-founders of Lyndra Therapeutics Inc....
...is developing oral drug delivery systems for ultra-long drug release. All of the candidates in Lyndra's...
BioCentury | Feb 1, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life. Lyndra...
...Lyndra is testing capsule formulations of generic drugs and proprietary compounds from partner companies. Lyndra...
...compound in 2019 and progress to a Phase II trial in 2020. Lyndra Therapeutics Inc., Watertown, Mass. Hongjiang Li Lyndra Therapeutics Inc. NMDA...
BioCentury | Jan 29, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life. Lyndra...
...Lyndra is testing capsule formulations of generic drugs and proprietary compounds from partner companies. Lyndra...
...an undisclosed schizophrenia compound in 2019 and progress to a Phase II trial in 2020. Hongjiang Li Lyndra Therapeutics Inc. NMDA...
BioCentury | Jan 23, 2018
Distillery Techniques

Drug delivery

...200-500 ng/mL for cabotegravir for up to a week post-dose. Next steps in collaboration with Lyndra...
...form for delivery of multiple antiretroviral (ART) agents LICENSING STATUS: Patent application filed; licensed to Lyndra...
Items per page:
1 - 10 of 19
BioCentury | Apr 2, 2021
Management Tracks

O’Brien to head NPC; plus moves at Frontier, Araris, Montis and more

...cell and gene therapy business at Cytiva, formerly known as GE Healthcare Life Sciences.Extended release drug developers Lyndra Therapeutics Inc....
...is stepping down as general partner at Google Ventures to launch his own venture firm, Byers Capital. BC Staff Lyndra Therapeutics Inc. Janux...
BioCentury | Oct 20, 2020
Management Tracks

J&J promotes Kumar; plus moves at Krystal, Design, Centogene, Lyndra, Mereo and Neoleukin

...was associate general counsel at the non-profit.Could an IPO soon be in the works for Lyndra Therapeutics Inc....
...companies public. The addition of  Eldridge is the third senior management hire this year for Lyndra...
...to serve on Mereo’s board. Danielle Golovin Krystal Biotech Inc. Design Therapeutics Inc. Mereo BioPharma Group plc Neoleukin Therapeutics Inc. Centogene N.V. Lyndra Therapeutics Inc....
BioCentury | Dec 6, 2019
Preclinical News

Dec. 5 Preclinical Quick Takes: Simpler synthesis of Merck’s HIV therapy; plus MRSA antibiotic, once-monthly oral contraceptive

...infected moth larvae. MIT’s once-monthly oral contraceptive A Massachusetts Institute of Technology team led by Lyndra Therapeutics Inc....
...contraceptive was detected in serum up to 29 days after oral delivery of the capsule. Lyndra...
...infectious and neurological diseases, transplant rejection and contraception (see “Star Treatment” ). BioCentury Staff Massachusetts Institute of Technology Lyndra Therapeutics Inc. MRSA antibiotic antimicrobial...
BioCentury | Oct 4, 2019
Company News

Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more

...CSO. Bellinger is an attending cardiologist at Brigham and Women's Hospital and was CSO at Lyndra Therapeutics Inc....
BioCentury | Jul 9, 2019
Company News

July 9 Company Quick Takes: Celgene, Nimbus expand deal; plus Gilead-Lyndra, Darzalex and more

...Gilead, Lyndra to develop long-acting HIV therapies Gilead Sciences Inc. (NASDAQ:GILD) gained exclusive rights from Lyndra Therapeutics Inc....
...Financial terms are undisclosed. Gilead participated in Lyndra's $60.9 million series B in January (see "Lyndra...
...Writer Darzalex, daratumumab (JNJ-54767414, humax-cd38) SP-1373, VPD-107 tislelizumab (BGB-A317) Alector Inc. Altimmune Inc. BeiGene Ltd. Gilead Sciences Inc. Johnson & Johnson WinterLight Labs Inc. Celgene Corp. Lyndra Therapeutics Inc. Nimbus...
BioCentury | Jun 3, 2019
Company News

Management tracks: Zai, Jazz, PTC, BIO and more

...biopharma division of the GE Healthcare unit of General Electric Co. (NYSE:GE). Drug delivery company Lyndra Therapeutics Inc....
...at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). Mark Zipkin, Staff Writer Biotechnology Innovation Organization Leo Pharma A/S PTC Therapeutics Inc. Jazz Pharmaceuticals plc Lyndra Therapeutics Inc. Zai...
BioCentury | Mar 13, 2019
Preclinical News

Langer study describes once-monthly dosing system for tuberculosis

...The scientific team behind drug delivery company Lyndra Therapeutics described a delivery device capable of releasing...
...treatment regimens last 6-9 months, according to the CDC. Langer and Traverso are co-founders of Lyndra Therapeutics Inc....
...is developing oral drug delivery systems for ultra-long drug release. All of the candidates in Lyndra's...
BioCentury | Feb 1, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life. Lyndra...
...Lyndra is testing capsule formulations of generic drugs and proprietary compounds from partner companies. Lyndra...
...compound in 2019 and progress to a Phase II trial in 2020. Lyndra Therapeutics Inc., Watertown, Mass. Hongjiang Li Lyndra Therapeutics Inc. NMDA...
BioCentury | Jan 29, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life. Lyndra...
...Lyndra is testing capsule formulations of generic drugs and proprietary compounds from partner companies. Lyndra...
...an undisclosed schizophrenia compound in 2019 and progress to a Phase II trial in 2020. Hongjiang Li Lyndra Therapeutics Inc. NMDA...
BioCentury | Jan 23, 2018
Distillery Techniques

Drug delivery

...200-500 ng/mL for cabotegravir for up to a week post-dose. Next steps in collaboration with Lyndra...
...form for delivery of multiple antiretroviral (ART) agents LICENSING STATUS: Patent application filed; licensed to Lyndra...
Items per page:
1 - 10 of 19